Muscat: The Civil Aviation Authority has announced that all passengers arriving to the Sultanate are required to present a COVID-19 vaccine certificate containing a QR Code stating that they have received two doses of a vaccine approved in Oman or in cases where a single dose is approved by the Health Authorities of Oman, have received one dose of such vaccine. The last dose is required to have been received not less than 14 days ahead of estimated arrival time.
All passengers arriving to the Sultanate that present a pre-travel negative result COVID-19 PCR test are exempted from quarantine.
The COVID-19 PCR test shall indicate the medical test result which can be validated and certified with a QR Code and the test should be conducted within 96 hours prior to the scheduled time of arrival in Oman, for international flights of more than eight hours duration, including transit, and 72 hours for shorter flights.
Passengers arriving to the Sultanate without holding a negative COVID-19 PCR test will be subject to a COVID-19 PCR test upon arrival where after the traveller shall be required to enter mandatory quarantine with electronic tracking bracelet until a negative PCR test result is received.
Meanwhile, passengers are required to complete pre-registration via Tarassud+ platform and must upload the vaccine certificate as well as a COVID-19 PCR certificate, both containing QR codes. “If the passenger prefers to conduct the COVID-19 PCR test upon arrival, the passengers shall pay the prescribed fees where registering via Tarassud + platform before boarding the aircraft,” CAA added.
However, in cases of a positive PCR test result, the passenger shall be required to undergo mandatory health isolation for 10 days starting from the test date. Except that passengers who have recovered from COVID-19 but tested positive on arrival are exempted from health isolation provided they are able to submit proof that they have completed the prescribed isolation period in the country where they were infected before travelling to the Sultanate.